Steele Glenn Jr Md Phd - Net Worth and Insider Trading

Steele Glenn Jr Md Phd Net Worth

The estimated net worth of Steele Glenn Jr Md Phd is at least $1 Million dollars as of 2024-11-13. Steele Glenn Jr Md Phd is the Director of WellCare Health Plans Inc and owns about 4,122 shares of WellCare Health Plans Inc (WCG) stock worth over $1 Million. Details can be seen in Steele Glenn Jr Md Phd's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steele Glenn Jr Md Phd has not made any transactions after 2017-08-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Steele Glenn Jr Md Phd

Steele Glenn Jr Md Phd Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Steele Glenn Jr Md Phd owns 4 companies in total, including PTC Therapeutics Inc (PTCT) , WellCare Health Plans Inc (WCG) , and Cepheid (CPHD) among others .

Click here to see the complete history of Steele Glenn Jr Md Phd’s form 4 insider trades.

Insider Ownership Summary of Steele Glenn Jr Md Phd

Ticker	Comapny	Transaction Date	Type of Owner
PTCT	PTC Therapeutics Inc	2017-01-03	director
WCG	WellCare Health Plans Inc	2018-05-23	director
CPHD	Cepheid	2016-11-04	director
		2009-10-22	director

Steele Glenn Jr Md Phd Latest Holdings Summary

Steele Glenn Jr Md Phd currently owns a total of 1 stock. Steele Glenn Jr Md Phd owns 4,122 shares of WellCare Health Plans Inc (WCG) as of August 10, 2017, with a value of $1 Million.

Latest Holdings of Steele Glenn Jr Md Phd

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
WCG	WellCare Health Plans Inc	2017-08-10	4,122	349.92	1,442,370

Holding Weightings of Steele Glenn Jr Md Phd

Steele Glenn Jr Md Phd Form 4 Trading Tracker

According to the SEC Form 4 filings, Steele Glenn Jr Md Phd has made a total of 0 transactions in WellCare Health Plans Inc (WCG) over the past 5 years. The most-recent trade in WellCare Health Plans Inc is the sale of 8,374 shares on August 10, 2017, which brought Steele Glenn Jr Md Phd around $1 Million.

Insider Trading History of Steele Glenn Jr Md Phd

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Steele Glenn Jr Md Phd Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Steele Glenn Jr Md Phd Ownership Network

Ownership Network List of Steele Glenn Jr Md Phd

No Data

Ownership Network Relation of Steele Glenn Jr Md Phd

Steele Glenn Jr Md Phd Owned Company Details

What does PTC Therapeutics Inc do?

Who are the key executives at PTC Therapeutics Inc?

Steele Glenn Jr Md Phd is the director of PTC Therapeutics Inc. Other key executives at PTC Therapeutics Inc include CHIEF FINANCIAL OFFICER Pierre Gravier , Chief Medical Officer Lee Scott Golden , and Chief Development Officer Matthew B. Klein .

PTC Therapeutics Inc (PTCT) Insider Trades Summary

Over the past 18 months, Steele Glenn Jr Md Phd made no insider transaction in PTC Therapeutics Inc (PTCT). Other recent insider transactions involving PTC Therapeutics Inc (PTCT) include a net sale of 22,039 shares made by Eric Pauwels , a net sale of 22,455 shares made by Matthew B. Klein , and a net sale of 2,701 shares made by Lee Scott Golden .

In summary, during the past 3 months, insiders sold 0 shares of PTC Therapeutics Inc (PTCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 114,302 shares of PTC Therapeutics Inc (PTCT) were sold and 7,700 shares were bought by its insiders, resulting in a net sale of 106,602 shares.

PTC Therapeutics Inc (PTCT)'s detailed insider trading history can be found in Insider Trading Tracker table.

PTC Therapeutics Inc Insider Transactions

No Available Data

What does WellCare Health Plans Inc do?

Who are the key executives at WellCare Health Plans Inc?

Steele Glenn Jr Md Phd is the director of WellCare Health Plans Inc. Other key executives at WellCare Health Plans Inc include director & Chief Executive Officer Kenneth A Burdick , EVP & General Counsel/Secretary Anat Hakim , and Chief Accounting Officer Maurice Hebert .

WellCare Health Plans Inc (WCG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of WellCare Health Plans Inc (WCG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of WellCare Health Plans Inc (WCG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

WellCare Health Plans Inc (WCG)'s detailed insider trading history can be found in Insider Trading Tracker table.

WellCare Health Plans Inc Insider Transactions

No Available Data

What does Cepheid do?

Who are the key executives at Cepheid?

Steele Glenn Jr Md Phd is the director of Cepheid. Other key executives at Cepheid include director & Chairman of the Board and CEO John L Bishop , EVP & Global Ops & Engineering Marc Haugen , and EVP & Chief Financial Officer Ilan Daskal .

Cepheid (CPHD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cepheid (CPHD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cepheid (CPHD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cepheid (CPHD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Cepheid Insider Transactions

No Available Data

What does Weis Markets Inc do?

Who are the key executives at Weis Markets Inc?

Steele Glenn Jr Md Phd is the director of Weis Markets Inc. Other key executives at Weis Markets Inc include SVP & Merchandising & Marketing Robert G. Gleeson , Sr. VP Merch. and Marketing Kurt A Schertle , and SVP & CFO and Treasurer Michael T Lockard .

Weis Markets Inc (WMK) Insider Trades Summary

Over the past 18 months, Steele Glenn Jr Md Phd made no insider transaction in Weis Markets Inc (WMK). Other recent insider transactions involving Weis Markets Inc (WMK) include a net purchase of 400 shares made by Robert G. Gleeson , a net purchase of 2,000 shares made by Kurt A Schertle , and a net purchase of 1,525 shares made by Lauth Edward John Iii .

In summary, during the past 3 months, insiders sold 0 shares of Weis Markets Inc (WMK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Weis Markets Inc (WMK) were sold and 3,925 shares were bought by its insiders, resulting in a net purchase of 3,925 shares.

Weis Markets Inc (WMK)'s detailed insider trading history can be found in Insider Trading Tracker table.

Weis Markets Inc Insider Transactions

No Available Data

Steele Glenn Jr Md Phd Mailing Address

Above is the net worth, insider trading, and ownership report for Steele Glenn Jr Md Phd. You might contact Steele Glenn Jr Md Phd via mailing address: 250 Technology Park, Lake Mary Fl 32746-6232.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.